Algorae Pharmaceuticals Limited (ASX:1AI)

Australia flag Australia · Delayed Price · Currency is AUD
0.0130
-0.0010 (-7.14%)
Mar 10, 2026, 4:10 PM AEST
160.00%
Market Cap 23.98M
Revenue (ttm) n/a
Net Income (ttm) -1.01M
Shares Out 1.71B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 381,933
Average Volume 1,296,860
Open 0.0130
Previous Close 0.0140
Day's Range 0.0130 - 0.0130
52-Week Range 0.0050 - 0.0240
Beta 0.14
RSI 29.62
Earnings Date Feb 24, 2026

About Algorae Pharmaceuticals

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer’s disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1987
Employees 48
Stock Exchange Australian Securities Exchange
Ticker Symbol 1AI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.